These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28099741)

  • 21. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study.
    Blanchard K; Lince-Deroche N; Fetters T; Devjee J; de Menezes ID; Trueman K; Sudhinaraset M; Nkonko E; Moodley J
    Contraception; 2015 Oct; 92(4):330-8. PubMed ID: 26162575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical abortion from 12 through 14 weeks' gestation: a retrospective study with 126 patients].
    Lavoué V; Vandenbroucke L; Grouin A; Briand E; Bauville E; Boyer L; Lemeut P; Bernard O; Poulain P; Morcel K
    J Gynecol Obstet Biol Reprod (Paris); 2011 Nov; 40(7):626-32. PubMed ID: 21741780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
    Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G
    BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misoprostol-induced abortions in Kosovo.
    Paçarada M; Zeqiri F; Kongjeli N; Kongjeli G; Obërtinca B
    Int J Gynaecol Obstet; 2011 Feb; 112(2):116-8. PubMed ID: 21130444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abortion care in Haiti: A secondary analysis of demographic and health data.
    Meffen K; Burkhardt G; Bartels S
    PLoS One; 2018; 13(11):e0206967. PubMed ID: 30408133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
    Mittal S; Agarwal S; Kumar S; Batra A
    Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
    Ravn P; Rasmussen A; Knudsen UB; Kristiansen FV
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1098-102. PubMed ID: 16232179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Service users' attributes associated with the uptake of medical versus surgical abortion at public health facilities in Vietnam.
    Ngo TD; Free C; Le HT; Edwards P; Pham KH; Nguyen YB; Nguyen TH
    Int J Gynaecol Obstet; 2014 Jun; 125(3):247-52. PubMed ID: 24698201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ob/Gyn training in abortion care: results from a national survey.
    Jackson CB; Foster AM
    Contraception; 2012 Oct; 86(4):407-12. PubMed ID: 22560184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Legalized abortions reduced maternal mortality in South Africa. Morbidity and mortality before and after the change of legislation].
    Bendz E; Liljequist VA; Bergström S
    Lakartidningen; 2008 Oct 8-14; 105(41):2855-7. PubMed ID: 19009900
    [No Abstract]   [Full Text] [Related]  

  • 38. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
    Blum J; Raghavan S; Dabash R; Ngoc Nt; Chelli H; Hajri S; Conkling K; Winikoff B
    Int J Gynaecol Obstet; 2012 Aug; 118(2):166-71. PubMed ID: 22682768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of evidence for safe abortion care.
    Kapp N; Whyte P; Tang J; Jackson E; Brahmi D
    Contraception; 2013 Sep; 88(3):350-63. PubMed ID: 23261233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.